Metformin is not a menopause treatment, but it can help with several metabolic shifts that happen during the menopausal transition. As estrogen levels drop, many women develop insulin resistance, gain weight around the midsection, and face rising cholesterol and blood sugar levels. Metformin targets these changes directly, and there is limited but intriguing evidence it may even ease hot flashes in some cases.
Why Menopause Changes Your Metabolism
Estrogen plays a significant role in how your body processes glucose and stores fat. During perimenopause and after menopause, declining estrogen shifts fat storage toward the abdomen, reduces insulin sensitivity, and raises the risk of metabolic syndrome. These aren’t just cosmetic changes. They increase your likelihood of developing type 2 diabetes and cardiovascular disease. Women who had normal blood sugar before menopause sometimes find themselves in the prediabetic range afterward, even without major changes in diet or activity.
Metformin works primarily in the liver, where it activates a cellular energy sensor that regulates how your body handles glucose and fat. This activation mimics some of the metabolic benefits of endurance exercise: it helps cells take up glucose more efficiently and reduces the amount of sugar your liver releases into the bloodstream. Because these cellular pathways are influenced by hormonal status, some researchers have looked specifically at whether metformin can counteract the metabolic disruption that comes with falling estrogen.
Weight and Body Composition
Midlife weight gain is one of the most frustrating aspects of menopause, and it’s the reason many women ask about metformin in the first place. In clinical trials of overweight women with features of metabolic syndrome, 12 months of metformin led to significant reductions in waist circumference and waist-to-hip ratio compared to placebo. These are meaningful markers because abdominal fat is the type most strongly linked to heart disease and diabetes risk.
That said, metformin is not a dramatic weight loss drug. The reductions in overall body weight in these trials were modest and did not always reach statistical significance compared to placebo. Where metformin seems to shine is in redistributing where fat sits on your body, shrinking the dangerous visceral fat around your organs even when the number on the scale doesn’t move much. If you’re looking for substantial weight loss, lifestyle changes like regular exercise and dietary shifts remain more effective, but metformin can provide a metabolic nudge in the right direction.
Cholesterol and Heart Health
Heart disease risk rises sharply after menopause, partly because of unfavorable changes in cholesterol. The picture with metformin here is nuanced and depends on whether you’re also using hormone therapy.
In the Diabetes Prevention Program, a large randomized trial that included postmenopausal women, metformin significantly lowered LDL (“bad”) cholesterol and raised HDL (“good”) cholesterol in women who were also taking hormone therapy. Among women not using hormone therapy, metformin had no significant effect on LDL or HDL. This suggests metformin and hormone therapy may work together on lipid metabolism in ways that neither achieves alone. One caution: metformin increased triglyceride levels in the hormone therapy group, which is worth monitoring since elevated triglycerides carry their own cardiovascular risks.
Can Metformin Reduce Hot Flashes?
This is probably the most surprising potential benefit. A clinical report described three patients with long-standing hot flashes, excessive sweating, and fatigue whose symptoms markedly improved on metformin. The proposed explanation is that high insulin levels (common in insulin-resistant women) can trigger the sympathetic nervous system, the body’s “fight or flight” response, producing flushing and sweating that feel identical to hormonal hot flashes. By lowering insulin levels, metformin may calm that overactive response.
This evidence is preliminary, based on a small number of patients rather than a large trial. But it raises an interesting possibility: if your hot flashes coincide with signs of insulin resistance (weight gain around the middle, elevated fasting glucose, fatigue after meals), metformin might address a root cause that hormone therapy alone wouldn’t touch.
Bone Density: No Clear Benefit
Bone loss accelerates after menopause, so it’s reasonable to wonder whether metformin helps here. A study from the Study of Women’s Health Across the Nation (SWAN) followed perimenopausal women with type 2 diabetes who started metformin and compared their bone mineral density changes to women not taking the drug. Over a median three-year follow-up, bone loss was essentially identical between the two groups at every site measured. Metformin does not appear to slow or worsen the bone loss that comes with menopause.
Brain Health and Cognitive Decline
Many women experience “brain fog” during menopause, and the long-term risk of dementia increases with age. Metformin users in a large observational study showed slower decline in global cognitive function compared to non-users, with the benefit concentrated in episodic memory (remembering specific events) and semantic memory (general knowledge and word recall). Metformin users also had less atherosclerosis and arteriosclerosis in brain blood vessels at autopsy, suggesting a vascular protective effect.
These findings come from people taking metformin for diabetes, so it’s unclear whether the cognitive benefit would extend to women without diabetes. The results are also observational, meaning they can’t prove metformin caused the slower decline. Still, for women already taking metformin for metabolic reasons, the cognitive data is encouraging rather than concerning.
Using Metformin Alongside Hormone Therapy
Metformin and hormone therapy are not an either/or choice. They target different aspects of the menopausal transition. Hormone therapy primarily addresses vasomotor symptoms (hot flashes, night sweats) and vaginal dryness, while metformin works on glucose metabolism and insulin sensitivity. The Diabetes Prevention Program data showing improved cholesterol profiles only in women combining metformin with hormone therapy suggests the two may complement each other.
Large meta-analyses in women with polycystic ovary syndrome (a condition with overlapping metabolic features) have found that combining metformin with hormonal therapy improves insulin resistance and glucose tolerance more effectively than hormonal therapy alone. While PCOS and menopause are different conditions, the underlying metabolic mechanisms overlap enough that these findings are relevant.
Side Effects and Practical Considerations
Metformin’s most common side effects are gastrointestinal: nausea, diarrhea, bloating, and a metallic taste. These typically improve after a few weeks, especially if you start at a low dose and increase gradually. The extended-release formulation tends to cause fewer stomach issues.
One risk that matters more for menopausal and postmenopausal women is vitamin B12 deficiency. Long-term metformin use can reduce B12 absorption, and deficiency becomes more common with age. Low B12 causes fatigue, numbness in the hands and feet, and cognitive symptoms that can easily be mistaken for menopause itself. If you take metformin for more than a year or two, periodic B12 monitoring is important. Kidney function also declines with age, and since metformin is cleared through the kidneys, your doctor will check kidney function before prescribing it and periodically afterward.
Metformin is not currently approved specifically for menopause-related metabolic changes. When prescribed in this context, it’s considered off-label use, typically for women who show signs of insulin resistance or prediabetes during the menopausal transition. Doses in clinical studies have generally ranged from 1,000 to 1,700 mg per day, similar to what’s used for type 2 diabetes.